Monograph
S01BC11 - Bromfenac |
Not porphyrinogenic |
NP |
Rationale
Bromfenac is administered locally in the eye and plasma concentrations are not quantifiable. The hepatic exposure is insignificant
Chemical description
Benzophenone
Therapeutic characteristics
Bromfenac is an anti-inflammatory agent used in the treatment of postoperative ocular inflammation following cataract extraction in adults. One drop is administered in the eye twice daily in two weeks after cataract extraction (SPC).
Hepatic exposure
Bromfenac has not been detected in plasma after ocular administration (SPC).
Metabolism and pharmacokinetics
In vitro studies indicate that bromfenac is metabolized by CYP2C9 (SPC).
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Summary of Product Characteristics | |
| 1. | Norwegian medicines agency. Summary of Product Characteristics (SPC). Yellox.
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Yellox 
Yellox 
Yellox 
Yellox 
Bromfenac · Yellox 
Yellox 
Yellox 
Brofestill · Infladrop · Yellox 
Yellox 
Yellox 
Yellox 
Yellox
© NAPOS 2025